🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Long term disease-free survival (DFS) of patients with acute myeloid leukem...
Status
Completed
Location
Unviersity Hospital of Münster (UKM)
Start Date
2011-06
Trial ID
NCT01361334
Treatments Being Tested
This phase I trial studies the side effects and best dose of pazopanib hydr...
Status
Completed
Location
Washington University School of Medicine
Start Date
2013-05-31
Trial ID
NCT01716416
The MOST Plus study is a two-period phase II clinical trial, conducted in p...
Status
Recruiting
Location
Institut Bergonié
Start Date
2014-03
Trial ID
NCT02029001
Pazopanib is FDA approved as a second line and beyond treatment for metasta...
Status
Completed
Location
Mayo Clinic - Phoenix
Start Date
2015-04-08
Trial ID
NCT02300545
Treatments Being Tested
Radiotherapy (RT) alone is able to induce a clinically significant effect w...
Status
Terminated
Location
Antoni van Leeuwenhoek
Start Date
2016-03-17
Trial ID
NCT02575066
Treatments Being Tested
To determine the response rate of pazopanib when administered as monotherap...
Status
Completed
Location
Samsung Cancer Center
Start Date
2010-04
Trial ID
NCT01099540
Treatments Being Tested
This phase II trial studies the side effects and how well pazopanib hydroch...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2008-02-22
Trial ID
NCT00625846
Treatments Being Tested
In this study will be examined whether alternating treatment between two cl...
Status
Completed
Location
St. Franciscus Gasthuis
Start Date
2011-11
Trial ID
NCT01408004
Treatments Being Tested
Disease and Stage: naïve metastatic kidney cancer. A multicenter, randomiz...
Status
Completed
Location
Hôpital Saint André, CHU de Bordeaux
Start Date
2017-05-31
Trial ID
NCT02960906
Treatments Being Tested
This study will determine whether blood tests, tumour imaging and tumour ti...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-18
Trial ID
NCT00992121
Treatments Being Tested